Skip to content

In the BioHarmony Drug Report Database

Bleomycin

Blenoxane (bleomycin) is a small molecule pharmaceutical. Bleomycin was first approved as Blenoxane on 1982-01-01. It is used to treat choriocarcinoma, hodgkin disease, melanoma, non-hodgkin lymphoma, and sarcoma amongst others in the USA.
Trade Name Blenoxane
Common Name Bleomycin
Indication choriocarcinoma, hodgkin disease, melanoma, non-hodgkin lymphoma, sarcoma, squamous cell carcinoma, teratocarcinoma, testicular neoplasms
Drug Class Antibiotics (Streptomyces strains)
Bleomycin
Get full access now